# SUR-7 continuation handoff — 2 November 2026

SUR-7 source fixes remain unchanged in the shared checkout. Per the operator's independent report, disposable-database regressions passed: realtime-client, smoke (1,321 API checks / 147 list endpoints), and integration (279 checks). These are source regressions, not UI acceptance. No tests were run in this continuation.

I updated `SUR-7-fix-log.md` and `full-stack-audit.md` with current downstream evidence from SUR-9: one reception and three admin sign-ins succeeded after natural cooldown with no failed attempts; UI-entered records through marker TEST-MGM-QA-020 and 10/10 registrations/vitals for markers 011–020 are recorded. Consultation notes, prescriptions, orders, follow-up, nurse workflows, and billing/payment remain untested or unavailable in Paper mode. SUR-8 ledger remains in progress; staged blocks are not passed.

No new independently confirmed code defect was reproduced. The receipt endpoint source guard was reviewed; it permits billing.view, payment.view, payment.collect, or finance.view, while the default doctor role has none and admin has `*`. The dedicated cross-role denial probe remains open. Account/role changes are neither needed nor authorized to construct a test identity.

No application login, port 4300 request, live DB access, campaign entry, credential/account/role/permission change, or source-code edit occurred. No deployment or push occurred. Existing operator-defined campaign ownership and all data/account restrictions remain in force.

Next: continue independent confirmed source fixes if a reproducible finding appears; coordinate UI and code-retest evidence with SUR-8; close the receipt denial probe only if it can be performed without account or role changes. Keep operational cloud-sync scope and off-device restore as owner/operations decisions.
